Top Markets
Coin of the day
China BCT Pharmacy Group, Inc. China BCT Pharmacy Group, Inc.

China BCT Pharmacy Group, Inc.

CNBI
주식 순위 #42162
China BCT Pharmacy Group, Inc. functions as a comprehensive pharmaceutical... China BCT Pharmacy Group, Inc. functions as a comprehensive pharmaceutical enterprise within the People's Republic of China, conducting its operations through various subsidiary companies. Its business activities are primarily categorized into three distinct divisions: Pharmaceutical Distribution, Retail Pharmacy, and Pharmaceutical Manufacturing. The Pharmaceutical Distribution division procures a diverse array of medicinal goods from various suppliers, subsequently supplying them to a broad client base that includes hospitals, retail drug stores, other wholesale distributors, clinics, medical centers, and individual consumers. Its extensive inventory, numbering approximately 8,000 distinct items, encompasses both branded and generic prescription medications, over-the-counter remedies, traditional Western and Chinese medicines, personal care products, medical supplies, Chinese herbal remedies, and medical instruments. Through its Retail Pharmacy segment, the company manages a network of 196 directly owned pharmacies, predominantly located in Guangxi province, operating under the "Baicaotang" brand. These outlets provide expert pharmaceutical services and offer a broad assortment of health-related products. This range includes prescription and non-prescription drugs, refined and roughly processed traditional Chinese herbal medicines, family planning items, and various other pharmaceutical and healthcare products. The Pharmaceutical Manufacturing division, operating under the "Asio" brand, is responsible for producing and marketing a range of generic and clinical pharmaceuticals. This includes treatments for inflammation and bacterial infections, oncology drugs, cardiovascular medications, and hepatitis therapies. Key products manufactured by the company include Levodopa, Tabellae Sarcandrae, Rotandine Sulfate, Corydalis Saxicola Bunting, and Ethacridine Lactate injection. The company was originally known as China Baicaotang Medicine Limited before adopting its current name, China BCT Pharmacy Group, Inc., in March 2010. Its corporate headquarters are situated in Liuzhou, People's Republic of China.
주가
$0.0001
마지막 동기화: 2025-06-02
시가총액
$3.82K
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
CN
거래 China BCT Pharmacy Group, Inc. (CNBI)

카테고리

B의 시가 총액을 가진 CNBI의 가격
China BCT Pharmacy Group, Inc. China BCT Pharmacy Group, Inc.
CNBI
$0.0001
의 시가총액 China BCT Pharmacy Group, Inc.(CNBI)
시가총액: $3.82K
August 2026 기준으로 China BCT Pharmacy Group, Inc.의 시가총액은 $3.82K입니다. 이는 당사 데이터에 따르면 China BCT Pharmacy Group, Inc.이 세계에서 42162nd번째로 가치 있는 기업임을 의미합니다. 시가총액은 상장된 회사의 발행 주식 총 시장 가치를 의미하며, 일반적으로 회사의 가치를 측정하는 데 사용됩니다.
2010부터 2026까지 China BCT Pharmacy Group, Inc.의 시가총액 기록
CNBI 가장 인기있는 상위 5 가지 stocks과 비교하여
CNBI의 가격 자산 b b의 시장 결과
China BCT Pharmacy Group, Inc. China BCT Pharmacy Group, Inc.
$141,094 $3.82K
$5.383T +141,094,292,751.11%
China BCT Pharmacy Group, Inc. China BCT Pharmacy Group, Inc.
$115,934 $3.82K
$4.423T +115,934,159,328.25%
China BCT Pharmacy Group, Inc. China BCT Pharmacy Group, Inc.
$109,041 $3.82K
$4.160T +109,040,531,695.15%
China BCT Pharmacy Group, Inc. China BCT Pharmacy Group, Inc.
$96,013.21 $3.82K
$3.663T +96,013,217,450.08%
China BCT Pharmacy Group, Inc. China BCT Pharmacy Group, Inc.
$75,777.19 $3.82K
$2.891T +75,777,195,420.53%